Projekt
PACIFIC AF
Abgeschlossen · 2020 bis 2021
Rickli Hans, Fink Karin, Vetsch Susanne
Art
Reichweite
Bereiche
Status
Start
Ende
Finanzierungsart
Kurzbeschreibung/Zielsetzung
Multicenter, randomized, active comparator-controlled, double-blind,
double-dummy, parallel group, dose-finding Phase 2 study to compare
the safety of the oral FXIa inhibitor BAY 2433334 to apixaban in
patients with atrial fibrillation
Primary Safety Endpoint
composite of International Society on
Thrombosis and Hemostasis (ISTH) major
and clinically relevant non-major bleeding
Intervention over 12 weeks and Safety Follow up after 2 weeks